Welcome to our dedicated page for Definitive Healthcare news (Ticker: DH), a resource for investors and traders seeking the latest updates and insights on Definitive Healthcare stock.
Company Overview
Definitive Healthcare Corp (DH) is a renowned provider of healthcare commercial intelligence and an expert in leveraging a robust SaaS platform to transform complex healthcare data into actionable insights. As a subscription-based service, it aggregates and refines vast amounts of information from a diverse array of healthcare providers including hospitals, physicians, ambulatory surgery centers, imaging centers, long-term care facilities, and more. Using advanced data science and analytics, the company delivers a comprehensive view of the healthcare ecosystem in the United States, empowering clients to develop data-driven strategies, segment markets accurately, and optimize commercial operations with confidence.
Business Model and Revenue Generation
The company’s business model is anchored in the provision of a versatile, subscription-driven platform that delivers uninterrupted access to high-quality, curated data. Rather than relying on periodic sales cycles or one-off engagements, Definitive Healthcare focuses on maintaining continuous customer relationships through its SaaS-based service offerings. Clients—all of whom are stakeholders in healthcare, from provider networks and pharmaceutical companies to medtech organizations and insurance companies—benefit from regular updates, quality-assured data, and seamless integration into their operational workflows. Revenue is generated mainly through recurring subscriptions and tailored support services, which reflects the company’s commitment to delivering ongoing value to its customers.
Key Solutions and Product Offerings
Definitive Healthcare has developed an extensive array of solutions designed to address the multi-dimensional needs of its users. Its product suite emphasizes:
- Comprehensive Data Aggregation: The platform curates data on thousands of healthcare facilities and professionals, facilitating market segmentation, competitive analysis, and strategic planning.
- Advanced Analytics and Data Science: Through the use of deep analytics, clients are provided with granular insights that help identify critical market trends and refined customer segments, essential for tailored go-to-market strategies.
- Mobile and On-Demand Intelligence: The DH View Suite mobile app ensures that crucial intelligence is accessible anywhere at any time, allowing sales and marketing teams to be prepared in real time.
- Predictive and Scenario Analysis: Tools such as Market Forecast enable organizations to visualize market trends and demand projections, equipping decision-makers with a forward-looking view of service line opportunities while remaining grounded in historical data and proven analytic models.
- Integrated Engagement Solutions: Through products like Monocl Conferences and Population Intelligence, the company facilitates seamless connection and collaboration among pharmaceutical companies, KOLs, and life science organizations, streamlining conference planning and audience targeting processes.
Data and Analytics Excellence
At the core of Definitive Healthcare’s offering is its commitment to accurate, comprehensive, and continuously updated data. The platform employs advanced methodologies to ensure that the information provided is not only extensive but also contextually enriched. Clients benefit from detailed profiles that extend beyond mere lists of providers to include insights into clinical performance, financial health, quality metrics, and the adoption of installed technologies. This meticulous approach to data quality ensures that healthcare professionals and corporate teams have both the breadth and depth of information required for thorough market research and intelligent strategic planning.
Market Position and Competitive Advantage
Within the crowded field of healthcare data providers, Definitive Healthcare distinguishes itself through its scale, the granularity of its data, and its ability to integrate diverse analytics into a holistic intelligence platform. The company serves multiple market segments, effectively bridging the gap between data generation and actionable intelligence. This approach not only supports traditional market research but also allows clinical and commercial teams to uncover new market opportunities, tailor their engagement strategies, and refine customer segmentation with exceptional precision. The combination of customizable tools and real-time access to data is a significant differentiator in an industry where time-sensitive insights can be the key to unlocking commercial success.
Client Impact and Applications
Definitive Healthcare’s impact is realized across various facets of the healthcare industry. For sales and marketing teams, the mobile-first solutions provide a tactical edge enabling pre-meeting preparation and post-engagement follow-up. Strategic planners and market analysts utilize advanced predictive tools like Market Forecast to identify emerging trends and allocate resources efficiently. Moreover, the integration of comprehensive data with intuitive platforms empowers organizations to recalibrate their go-to-market strategies, optimize operational performance, and achieve cost efficiencies without sacrificing the quality of engagement. The platform’s design is inherently flexible, catering to the unique requirements of diverse client types—from academic medical centers to global pharmaceutical corporations—thus ensuring that every customer derives maximum value from their investment in data-driven insights.
Expertise, Experience, and Industry Authority
Definitive Healthcare embodies the principles of Expertise, Experience, Authoritativeness, and Trustworthiness (E-E-A-T) in every facet of its operations. The company employs industry veterans and data scientists who specialize in healthcare analytics, ensuring that the intelligence provided is rooted in practical experience and rigorous analysis. Its commitment to accuracy and depth is reflected in every aspect of its data curation process, with an unwavering focus on eliminating inaccuracies and delivering value through meticulous data management. This disciplined approach to quality control not only elevates the standard of commercial intelligence in the healthcare arena but also instills trust among its clients, who rely on the platform for critical decision-making and strategic direction. Additionally, the company’s open engagement with its marketplace through educational webinars, conference presentations, and thought leadership articles further underscores its standing as a bidder of expert insight in the dynamic healthcare landscape.
Operational Excellence and Integration
Operationally, the company is designed for adaptability and precision. Its cloud-based infrastructure allows for seamless updates and integration with internal systems, ensuring that organizations do not encounter disruptions in their workflows. Whether accessed via desktop or mobile devices, the platform’s intuitive interface facilitates a smooth user experience. This operational excellence has made it a critical tool for organizations that need to remain agile in response to rapid changes in market conditions and technological advances. With an emphasis on continuous improvement and innovation, Definitive Healthcare frequently enhances its product offerings, incorporating refined analytics, enhanced user interface features, and expanded data points that collectively offer a potent mix of depth, detail, and usability.
Industry Insights and Continuous Learning
The company’s overarching mission is to transform fragmented data sources into a cohesive intelligence framework that supports the dynamic needs of modern healthcare professionals. Its expansive database serves as both a repository of historical trends and a catalyst for future innovation, enabling clients to stay ahead by basing strategies on robust, integrative intelligence. By powering strategic conversations around healthcare trends, patient demographics, and market dynamics, Definitive Healthcare is not only addressing current challenges but also enabling its clients to anticipate future developments with a well-informed perspective. The platform’s capacity to integrate real-time data with predictive analytics creates a compelling value proposition for stakeholders looking to fortify their competitive positioning in a constantly evolving healthcare landscape.
Conclusion
In summary, Definitive Healthcare Corp stands out as a key provider of healthcare commercial intelligence, renowned for its comprehensive data platform, advanced analytical tools, and commitment to delivering precise, actionable insights. Through its diverse suite of products and an unwavering focus on operational excellence and data quality, the company facilitates informed strategic decision-making and robust market intelligence across the healthcare industry. Whether for identifying new market opportunities, optimizing sales strategies, or refining operational approaches, the platform’s capacity to integrate data, analytics, and real-world expertise underscores its essential role in navigating the complexities of today’s healthcare market.
Definitive Healthcare (Nasdaq: DH) has announced the granting of inducement awards to its newly hired senior leader. The company's Human Capital Management and Compensation Committee approved inducement awards for Jeff Moyer, who joins as SVP of Growth and Sales Operations.
The awards include 364,432 time-based restricted stock units (RSUs), effective April 3, 2025. The RSUs will vest according to the following schedule: 25% on April 1, 2026, with the remaining amount vesting in quarterly installments of 6.25% over the subsequent three years. These awards were granted under Definitive Healthcare's 2023 Inducement Plan and comply with Nasdaq Listing Rule 5635(c)(4).
Definitive Healthcare (Nasdaq: DH) announced inducement awards for two newly hired senior leaders. The company granted 172,414 time-based restricted stock units (RSUs) to Kate Hastings, the new Chief Customer Officer, and 1,018,330 RSUs to Benjamin Graboske, the new EVP, Technology, Engineering and Chief Data Officer, both effective March 3, 2025.
The awards, granted under Nasdaq Listing Rule 5635(c)(4) and Definitive Healthcare's 2023 Inducement Plan, feature a vesting schedule where 25% vests initially (February 1, 2026 for Hastings; April 1, 2026 for Graboske), with the remainder vesting quarterly at 6.25% over three years, subject to continued employment.
Definitive Healthcare (DH) reported mixed Q4 and full-year 2024 results. Q4 revenue declined 6% to $62.3 million, while full-year revenue slightly increased to $252.2 million. The company recorded significant goodwill impairment charges of $97.1 million in Q4 and $688.9 million for the full year.
Q4 highlights include: Net Loss of $(84.7) million, Adjusted Net Income of $12.6 million, and Adjusted EBITDA of $17.5 million (28% margin). Full-year metrics showed improvement in cash flow operations, up 41% to $58.2 million, and Unlevered Free Cash Flow increased 6% to $72.5 million.
The company announced Casey Heller will become CFO effective June 2, 2025. For 2025, DH projects revenue between $230.0-$240.0 million and Adjusted EBITDA of $61.0-$65.0 million with 26-28% margin.
Definitive Healthcare (Nasdaq: DH), a leader in healthcare commercial intelligence, has announced its participation in the upcoming Raymond James 2025 Institutional Investors Conference. CEO Kevin Coop and CFO Rick Booth will deliver a presentation on Tuesday, March 4, 2025, at 3:25 p.m. Eastern Time.
Investors and interested parties can access the live presentation through a webcast available on the Events page of Definitive Healthcare's investor relations website at https://ir.definitivehc.com/. A recorded version of the presentation will be accessible for a time after the event.
Definitive Healthcare (Nasdaq: DH), a healthcare commercial intelligence company, has scheduled its fourth quarter and full year 2024 financial results announcement for Thursday, February 27, 2025, after market close. The company will host a conference call and webcast at 5:00 PM (ET) / 2:00 PM (PT) to discuss the results.
Investors can access the live audio webcast through the company's Investor Relations website at ir.definitivehc.com. A dial-in option will be available at 877-358-7298 (domestic) or +1-848-488-9244 (international). A replay will be accessible through March 29, 2025, using 800-645-7964 or 757-849-6722 with passcode 1765#.
Definitive Healthcare (Nasdaq: DH) has been named among Built In's 100 Best Places to Work in Boston for 2025. The recognition, which includes companies of various sizes and both remote-first and traditional employers, highlights DH's commitment to employee satisfaction and workplace culture.
CEO Kevin Coop emphasized the company's focus on making an impact in healthcare and fostering a culture of innovation where employees are empowered to contribute. The selection process by Built In evaluated compensation, benefits, and various workplace attributes including remote work opportunities, DEI programs, and cultural offerings.
The company offers notable benefits including unlimited PTO, hybrid work options, and half-day Summer Fridays for U.S. employees. DH also provides extensive professional development opportunities through continuous learning, leadership development, and educational support programs. This recognition reflects the company's dedication to creating an environment where innovation and individual growth flourish while maintaining work-life balance.
Definitive Healthcare (Nasdaq: DH), a leader in healthcare commercial intelligence, has announced its participation in the 27th Annual Needham Growth Conference. CEO Kevin Coop and CFO Rick Booth will deliver a presentation on Wednesday, January 15, 2025, at 2:15 p.m. Eastern Time.
Definitive Healthcare reported Q3 2024 financial results with revenue of $62.7 million, a 4% decrease from Q3 2023. Net loss was $(187.8) million, including goodwill impairment charges of $228.2 million. Adjusted net income rose to $15.4 million from $14.6 million, while adjusted EBITDA fell 5% to $20.6 million. Cash flow from operations was $19.4 million, and unlevered free cash flow was $24.3 million. The company announced a $100 million stock repurchase program starting in 2025. Customer base grew to 530 enterprise clients. CFO Richard Booth will leave by June 1, 2025. Q4 2024 revenue guidance is $60.0-$61.0 million, adjusted net income $10.5-$11.5 million, and full-year 2024 revenue is expected to be $250.0-$251.0 million.
Definitive Healthcare (Nasdaq: DH) has scheduled its third quarter 2024 financial results announcement for Thursday, November 7, 2024, after market close. The healthcare commercial intelligence company will host a conference call and webcast at 5:00 PM (ET) / 2:00 PM (PT) to discuss the results. Investors can access the live audio webcast on the company's IR website and join via phone using domestic (877-358-7298) or international (+1-848-488-9244) dial-in numbers. A replay will be available until December 7, 2024.
Definitive Healthcare (Nasdaq: DH) has launched Monocl Conferences, a solution designed to enhance conference planning and participation for life science organizations. This intuitive platform provides medical affairs, marketing, and conference planning teams with rich, contextualized conference data and access to key experts.
Key features include:
- Visualized conference data dashboard
- Searchable conference insights
- Comparable data for monitoring trends
Monocl Conferences offers quick access to presentations, competitor analysis, social media insights, and details about centers of excellence. It aims to streamline planning, drive strategic engagement, and support organizations in delivering innovative therapies and medical devices to improve patient outcomes.
FAQ
What is the current stock price of Definitive Healthcare (DH)?
What is the market cap of Definitive Healthcare (DH)?
What is Definitive Healthcare Corp?
How does Definitive Healthcare generate revenue?
What types of healthcare providers are included in its data?
How does the DH platform aid in strategic planning?
What are some of the key product offerings of Definitive Healthcare?
Who are the typical clients of Definitive Healthcare?
How is data quality maintained on the platform?
How does Definitive Healthcare differentiate itself from competitors?
